Welcome to our dedicated page for Birchtech SEC filings (Ticker: BCHT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the story behind Birchtech Corp’s mercury-capture royalties or PFAS pilot wins? This dedicated SEC filings hub puts every disclosure within easy reach, from the latest Birchtech Corp quarterly earnings report 10-Q filing to real-time Birchtech Corp Form 4 insider transactions.
Stock Titan’s AI reads the dense prose for you, surfacing the numbers and risks that matter. Want patent-litigation updates? Our engine flags them in the next Birchtech Corp 8-K material events explained summary. Need to monitor option grants? Get instant alerts on Birchtech Corp executive stock transactions Form 4. Curious how new feedstock agreements affect margins? The AI highlights that narrative inside each MD&A section so you can act before the market digests it.
Here’s how professionals use this page:
- Track segment revenue shifts across ME2C and WE2C without reading 200 pages of the annual report—see the Birchtech Corp annual report 10-K simplified card.
- Compare quarter-over-quarter PFAS remediation sales with one-click charts generated from 10-Q data.
- Review board compensation trends inside every Birchtech Corp proxy statement executive compensation filing.
All forms—10-K, 10-Q, 8-K, S-1, and the hard-to-find Birchtech insider trading Form 4 transactions—arrive here moments after hitting EDGAR. Each comes with an earnings report filing analysis and plain-English answers to common questions, like “How is SEA® sorbent revenue growing?” or “Are directors buying shares?”. In short, understanding Birchtech Corp SEC documents with AI starts here—so you spend minutes, not hours, turning disclosures into decisions.
Birchtech Corp. (BCHT) filed its Q3 2025 report, showing a return to profitability for the quarter alongside a going concern warning. Revenue was $7.36M vs $5.24M a year ago, driven by $2.60M of license revenue and $4.72M of product sales. Gross profit reached $4.03M, and net income was $788,012, compared with a $458K loss last year.
For the nine months, revenue was $13.84M and the company posted a net loss of $2.43M. Cash was $1.77M at September 30, 2025, and management disclosed a working capital deficiency of about $5.0M, citing substantial doubt about continuing as a going concern. The balance sheet reflected a profit share liability of $7.62M measured on a Level 3 basis.
The company highlighted progress in patent enforcement and licensing, including a prior $57.1M jury verdict and multiple utility license agreements. Common shares outstanding were 96,866,109 as of November 13, 2025.